Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

37.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.8K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.9K
2.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.4K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

5.2K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inactivation of Focal Adhesion Kinase FAK Rapidly Abrogates Keratinocyte Entry in Mitosis via Rho-Associated Kinase, Resulting in Squamous Differentiation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Honoring Daniel Aberdam's scientific and human legacy.

Cell death & disease·2025
Same author

Sumo-regulatory SENP2 controls the homeostatic squamous mitosis-differentiation checkpoint.

Cell death & disease·2024
Same author

DNA damage signalling histone H2AX is required for tumour growth.

Cell death discovery·2024
Same author

DNA damage triggers squamous metaplasia in human lung and mammary cells via mitotic checkpoints.

Cell death discovery·2023
Same author

Shiga Toxin-B Targeted Gold Nanorods for Local Photothermal Treatment in Oral Cancer Clinical Samples.

International journal of nanomedicine·2022

Related Experiment Video

Updated: Dec 4, 2025

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
06:25

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Published on: February 10, 2023

2.3K

p21CIP1 controls the squamous differentiation response to replication stress.

Isabel de Pedro1, Jesús Galán-Vidal1, Ana Freije1

  • 1Cell Cycle, Stem Cell Fate and Cancer Laboratory, Institute for Research Marqués de Valdecilla (IDIVAL), 39011, Santander, Spain.

Oncogene
|October 24, 2020
PubMed
Summary

The cell cycle inhibitor p21 (also known as p21CIP1) is crucial for controlling cell fate, driving differentiation in response to DNA damage. Its absence allows damaged cells to proliferate or undergo apoptosis, impacting cancer development.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.1K
Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

14.5K

Related Experiment Videos

Last Updated: Dec 4, 2025

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
06:25

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Published on: February 10, 2023

2.3K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.1K
Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

14.5K

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Cell fate control is vital for tissue homeostasis and cancer development.
  • The cell cycle inhibitor p21CIP1 plays a paradoxical role in cell fate decisions like senescence, apoptosis, and differentiation.
  • p21CIP1 is a key target of the tumor suppressor p53 but also has independent regulatory pathways.

Purpose of the Study:

  • To investigate the role of p21CIP1 in the squamous differentiation response to cell cycle deregulation and replication stress.
  • To elucidate the mechanisms by which p21CIP1 controls cell fate in squamous epithelia.
  • To understand the dual role of p21CIP1 in keratinocyte response to genomic stress.

Main Methods:

  • Investigated the role of endogenous p21CIP1 in human primary keratinocytes.
  • Examined the effects of p53 loss and Cyclin E overexpression on differentiation.
  • Analyzed the impact of p21CIP1 inactivation on cell cycle progression and DNA damage response.
  • Studied keratinocyte apoptosis following UV irradiation in the absence of p21CIP1.

Main Results:

  • p21CIP1 is essential for the mitosis block required for squamous differentiation following cell cycle deregulation and replication stress.
  • Inactivation of p21CIP1 in keratinocytes reduced differentiation in response to p53 loss or Cyclin E overexpression.
  • Bypassing the p21CIP1-induced mitotic block, via Cyclin B upregulation, allowed DNA-damaged cells to proliferate.
  • Loss of p21CIP1 promoted apoptosis over differentiation in UV-irradiated keratinocytes.

Conclusions:

  • p21CIP1 is required to promote keratinocyte differentiation in response to genomic stress.
  • The study highlights the dual and paradoxical role of p21CIP1 in carcinogenesis.
  • Understanding p21CIP1's function is critical for developing cancer therapies targeting cell fate.